These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 2297747)
1. Immunolymphoscintigraphy with 99mTc-labeled monoclonal antibody (BW 431/26) reacting with carcinoembryonic antigen in breast cancer. Kairemo KJ Cancer Res; 1990 Feb; 50(3 Suppl):949s-954s. PubMed ID: 2297747 [TBL] [Abstract][Full Text] [Related]
2. Immunolymphoscintigraphy for the detection of lymph node metastases from breast cancer. Tjandra JJ; Russell IS; Collins JP; Andrews JT; Lichtenstein M; Binns D; McKenzie IF Cancer Res; 1989 Mar; 49(6):1600-8. PubMed ID: 2647290 [TBL] [Abstract][Full Text] [Related]
3. Differentiation of lymph-node metastases by anti-CEA immunoscintigraphy in a patient with follicular thyroid and breast cancer. Lind P; Lechner P; Kuttnig M; Klimpfinger M; Langsteger W; Költringer P; Cesnik H; Eber O Nuklearmedizin; 1990 Dec; 29(6):278-81. PubMed ID: 1963681 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy and tumor-targeting kinetics of complete versus fragmented 99mTc-labeled anti-carcinoembryonic antigen antibodies: an intraindividual comparison. Behr TM; Becker WS; Klein MW; Bair HJ; Scheele JR; Wolf FG Cancer Res; 1995 Dec; 55(23 Suppl):5786s-5793s. PubMed ID: 7493347 [TBL] [Abstract][Full Text] [Related]
5. Clinical studies of cancer radioimmunodetection with carcinoembryonic antigen monoclonal antibody fragments labeled with 123I or 99mTc. Goldenberg DM; Goldenberg H; Sharkey RM; Higginbotham-Ford E; Lee RE; Swayne LC; Burger KA; Tsai D; Horowitz JA; Hall TC Cancer Res; 1990 Feb; 50(3 Suppl):909s-921s. PubMed ID: 2297741 [TBL] [Abstract][Full Text] [Related]
6. Lymphoscintigraphy with radionuclide-labeled antibodies to carcinoembryonic antigen. DeLand FH; Kim EE; Goldenberg DM Cancer Res; 1980 Aug; 40(8 Pt 2):2997-3000. PubMed ID: 7397695 [TBL] [Abstract][Full Text] [Related]
7. [Successful immunoscintigraphic tumor detection with technetium 99m marked monoclonal anti-CEA antibodies]. Baum RP; Lorenz M; Hertel A; Baew-Christow T; Schwarz A; Hör G Onkologie; 1989 Aug; 12 Suppl 1():26-9. PubMed ID: 2685692 [TBL] [Abstract][Full Text] [Related]
8. Studies of breast cancer imaging with radiolabeled antibodies to carcinoembryonic antigen. Immunomedics Breast Cancer Study Group. Goldenberg DM; Wegener W Acta Med Austriaca; 1997; 24(2):55-9. PubMed ID: 9227788 [TBL] [Abstract][Full Text] [Related]
9. In vivo radioimmunological lymphoscintigraphy in cancer: the implications of positive findings. Deland FH; Goldenberg DM J Can Assoc Radiol; 1982 Mar; 33(1):4-9. PubMed ID: 7076707 [TBL] [Abstract][Full Text] [Related]
10. [Initial results of immunolymphoscintigraphy in the diagnosis of axillary lymph node involvement in breast cancer patients]. Pateisky N; Philipp K; Kubista E; Skodler WD; Burchell J Geburtshilfe Frauenheilkd; 1986 Oct; 46(10):681-4. PubMed ID: 3803863 [TBL] [Abstract][Full Text] [Related]
11. Detection efficiency of colorectal carcinoma recurrence using technetium pertechnetate-anti-carcinoembryonic antigen monoclonal antibody BW 431/26. Zwas ST; Goshen E; Rath P; Brenner H; Klein E; Ben-Ari G Cancer; 1995 Jul; 76(2):215-22. PubMed ID: 8625094 [TBL] [Abstract][Full Text] [Related]
12. [Anaphylactic shock after repeated injection of 99mTc-labeled CEA antibody]. Rettenbacher L; Galvan G Nuklearmedizin; 1994 Jun; 33(3):127-8. PubMed ID: 8090628 [TBL] [Abstract][Full Text] [Related]
13. [The clinical relevance of anti-CEA immunoscintigraphy with the 99mTc-labelled monoclonal antibody BW 431/26. A critical assessment after 119 studies]. Hach A; Wittig B; Piepenburg R; Steinert H; Lahmann C; Dippold W; Hahn K Rofo; 1992 Jul; 157(1):3-10. PubMed ID: 1638001 [TBL] [Abstract][Full Text] [Related]
14. [Anti-CEA immunoscintigraphy in postoperative follow-up of tumor patients. Differentiated use of various monoclonal antibody preparations]. Leitha T; Baur M; Steger G; Dudczak R Wien Klin Wochenschr; 1990 Sep; 102(17):503-9. PubMed ID: 2264338 [TBL] [Abstract][Full Text] [Related]
15. 99mTc-anti-CEA radioimmunoscintigraphy of lung adenocarcinoma. Leitha T; Walter R; Schlick W; Dudczak R Chest; 1991 Jan; 99(1):14-9. PubMed ID: 1984945 [TBL] [Abstract][Full Text] [Related]
16. Preoperative imaging of colorectal carcinoma with 111In-labeled anticarcinoembryonic antigen monoclonal antibody. Beatty JD; Duda RB; Williams LE; Sheibani K; Paxton RJ; Beatty BG; Philben VJ; Werner JL; Shively JE; Vlahos WG Cancer Res; 1986 Dec; 46(12 Pt 1):6494-502. PubMed ID: 3779657 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients. McLean RG; Ege GN J Nucl Med; 1986 Jul; 27(7):1116-24. PubMed ID: 3723187 [TBL] [Abstract][Full Text] [Related]
18. Diagnosis of breast carcinoma with radiolabeled monoclonal antibodies (MoAbs) to carcinoembryonic antigen (CEA) and human milk fat globulin (HMFG). Rosner D; Nabi H; Wild L; Ortman-Nabi J; Hreshchyshyn MM Cancer Invest; 1995; 13(6):573-82. PubMed ID: 7583706 [TBL] [Abstract][Full Text] [Related]
19. Immunolymphoscintigraphy of pulmonary and mediastinal lymph nodes in dogs: a new approach to lung cancer imaging. Mulshine JL; Keenan AM; Carrasquillo JA; Walsh T; Linnoila RI; Holton OD; Harwell J; Larson SM; Bunn PA; Weinstein JN Cancer Res; 1987 Jul; 47(13):3572-6. PubMed ID: 3472655 [TBL] [Abstract][Full Text] [Related]
20. [Immunolymphoscintigraphy. A new procedure for noninvasive lymph node staging illustrated by the example of breast cancer]. Pateisky N; Schatten C; Enzelsberger H; Czerwenka K; Burchell J; Mandeville R Dtsch Med Wochenschr; 1988 Feb; 113(7):250-5. PubMed ID: 3342737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]